title: [Diabetic maculopathy - classification and therapy].
abstract: The current clinical classification into focal, diffuse, and ischaemic maculopathy is useful with respect to pathomechanism and therapy. This review discusses the value of standard therapeutical options as well as the recent surgical and pharmacological approaches.
authors.affiliation: Abteilung für Netzhaut- und Glaskörperchirurgie des Zentrums für Augenheilkunde und Zentrum für Molekulare Medizin, Universität zu Köln.
authors.forename: Sascha
authors.initials: S
authors.lastname: Fauser
authors.forename: Tim U
authors.initials: TU
authors.lastname: Krohne
authors.forename: Bernd
authors.initials: B
authors.lastname: Kirchhof
authors.forename: Antonia M
authors.initials: AM
authors.lastname: Joussen
mesh_terms: D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003922:Diabetes Mellitus, Type 1 / Q000145:classification / Q000175:diagnosis / Q000628:therapy; D003930:Diabetic Retinopathy / Q000145:classification / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007267:Injections; D017075:Laser Coagulation; D008269:Macular Edema / Q000145:classification / Q000175:diagnosis / Q000628:therapy*; D014222:Triamcinolone Acetonide / Q000008:administration & dosage; D014821:Vitrectomy; D018630:Vitreoretinopathy, Proliferative / Q000628:therapy; D014822:Vitreous Body
chemical_list: D014222:Triamcinolone Acetonide
vernacular_title: Die diabetische Makulopathie - Klinik und Therapie.